Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

925 Periodical Search Results

You searched for "atypical" AND "antipsychotics" OR "neuroleptic" OR "antipsychotic drug" OR "antipsychotic agent" OR "antipsychotic agents" OR "anti-psychotic agent" within Schizophrenia Research

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 925 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

display abstract citation download email a colleague
Display:

  1. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study
    Manuel J Cuesta, Victor Peralta, Amalia Zarzuela
    Schizophrenia Research
    1 March 2001 (Vol. 48, Issue 1, Pages 17-28)
    Abstract | Full Text | Full-Text PDF (115 KB)

  1. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia , 28 June 2007
    C. Daniel Mullins, Nour A. Obeidat, Brian J. Cuffel, John Naradzay, Antony D. Loebel
    Schizophrenia Research
    January 2008 (Vol. 98, Issue 1, Pages 8-15)
    Abstract | Full Text | Full-Text PDF (259 KB)

  1. Tardive dyskinesia and atypical antipsychotic drugs
    Daniel E. Casey
    Schizophrenia Research
    1 March 1999 (Vol. 35Supplement 1, Pages S61-S66)
    Abstract | Full Text | Full-Text PDF (108 KB)

  1. Neuroleptic-induced hyperprolactinemia
    Ruth A. Dickson, William M. Glazer
    Schizophrenia Research
    1 March 1999 (Vol. 35Supplement 1, Pages S75-S86)
    Abstract | Full Text | Full-Text PDF (120 KB)

  1. Prolactin and antipsychotic medications: mechanism of action
    Richard G. Petty
    Schizophrenia Research
    1 March 1999 (Vol. 35Supplement 1, Pages S67-S73)
    Abstract | Full Text | Full-Text PDF (131 KB)

  1. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics
    Xiang Yang Zhang, Yun Long Tan, Lian Yuan Cao, Gui Ying Wu, Qi Xu, Yan Shen, Dong Feng Zhou
    Schizophrenia Research
    31 January 2006 (Vol. 81, Issue 2, Pages 291-300)
    Abstract | Full Text | Full-Text PDF (136 KB)

  1. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): Results of a 6-week, randomized, placebo-controlled study , 28 April 2007
    Michael Davidson, Robin Emsley, Michelle Kramer, Lisa Ford, Guohua Pan, Pilar Lim, Mariëlle Eerdekens
    Schizophrenia Research
    July 2007 (Vol. 93, Issue 1, Pages 117-130)
    Abstract | Full Text | Full-Text PDF (329 KB)

  1. Switching from conventional to novel antipsychotic drugs: results of a prospective naturalistic study
    L Voruganti, L Cortese, L Owyeumi, V Kotteda, Z Cernovsky, S Zirul, A Awad
    Schizophrenia Research
    1 October 2002 (Vol. 57, Issue 2, Pages 201-208)
    Abstract | Full Text | Full-Text PDF (105 KB)

  1. Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist
    Cai Song, Ai-hua Lin, Gunter Kenis, Eugene Bosmans, Michael Maes
    Schizophrenia Research
    7 April 2000 (Vol. 42, Issue 2, Pages 157-164)
    Abstract | Full Text | Full-Text PDF (97 KB)

  1. The effects of antipsychotic therapy on serum lipids: a comprehensive review
    Jonathan M Meyer, Carol E Koro
    Schizophrenia Research
    1 September 2004 (Vol. 70, Issue 1, Pages 1-17)
    Abstract | Full Text | Full-Text PDF (232 KB)

  1. Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
    Guy Chouinard, Howard C. Margolese
    Schizophrenia Research
    15 July 2005 (Vol. 76, Issue 2, Pages 247-265)
    Abstract | Full Text | Full-Text PDF (179 KB)

  1. Treatment of a first episode of psychotic illness with quetiapine: An analysis of 2 year outcomes
    Lili C. Kopala, Kimberley P. Good, Heather Milliken, Christine Buiteman, Hazel Woodley, Qing Rui, David Whitehorn, Leslie Love, Robert Balshaw, Ivan Kiss, William G. Honer
    Schizophrenia Research
    1 January 2006 (Vol. 81, Issue 1, Pages 29-39)
    Abstract | Full Text | Full-Text PDF (165 KB)

  1. Association of plasma apolipoproteins D with RBC membrane arachidonic acid levels in schizophrenia
    Jeffrey K. Yao, Elizabeth A. Thomas, Ravinder D. Reddy, Matcheri S. Keshavan
    Schizophrenia Research
    1 January 2005 (Vol. 72, Issue 2, Pages 259-266)
    Abstract | Full Text | Full-Text PDF (192 KB)

  1. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia , 13 February 2008
    Rajiv Tandon, R.H. Belmaker, Wagner F. Gattaz, Juan J. Lopez-Ibor, Ahmed Okasha, Bruce Singh, Dan J. Stein, Jean-Pierre Olie, W. Wolfang Fleischhacker, Hans-Juergen Moeller, for the Section of Pharmacopsychiatry, World Psychiatric Association
    Schizophrenia Research
    March 2008 (Vol. 100, Issue 1, Pages 20-38)
    Abstract | Full Text | Full-Text PDF (707 KB)

  1. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)
    Rajiv Tandon, Ronald N. Marcus, Elyse G. Stock, Linda C. Riera, Dusan Kostic, Miranda Pans, Robert D. McQuade, Margaretta Nyilas, Taro Iwamoto, David T. Crandall
    Schizophrenia Research
    May 2006 (Vol. 84, Issue 1, Pages 77-89)
    Abstract | Full Text | Full-Text PDF (363 KB)

  1. Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: A double-blind, randomized, placebo-controlled study , 07 September 2006
    Zhang-Jin Zhang, Wan-Hu Kang, Qiang Li, Xue-Yi Wang, Shao-Min Yao, Ai-Qun Ma
    Schizophrenia Research
    December 2006 (Vol. 88, Issue 1, Pages 102-110)
    Abstract | Full Text | Full-Text PDF (230 KB)

  1. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance , 26 June 2008
    Kirsten Lykkegaard, Philip J. Larsen, Niels Vrang, Camilla Bock, Troels Bock, Lotte Bjerre Knudsen
    Schizophrenia Research
    August 2008 (Vol. 103, Issue 1, Pages 94-103)
    Abstract | Full Text | Full-Text PDF (440 KB)

  1. Medical-claims databases in the design of a health-outcomes comparison of quetiapine (`Seroquel'1) and usual-care antipsychotic medication
    Walter W Hong, Ihor W Rak, Vincent T Ciuryla, Anastasia M Wilson, Jelle W Kylstra, Herbert Y Meltzer, William T Carpenter, Anthony Lehman, Lisa A Arvanitis
    Schizophrenia Research
    22 June 1998 (Vol. 32, Issue 1, Pages 51-58)
    Abstract | Full Text | Full-Text PDF (110 KB)

  1. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials
    Stephen R. Marder, Robert D. McQuade, Elyse Stock, Stephen Kaplita, Ronald Marcus, Allan Z. Safferman, Anutosh Saha, Mirza Ali, Taro Iwamoto
    Schizophrenia Research
    1 June 2003 (Vol. 61, Issue 2, Pages 123-136)
    Abstract | Full Text | Full-Text PDF (342 KB)

  1. Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand , 10 September 2009
    Yang Guo, Hai Zhang, Xuetao Chen, Wenxian Cai, Jianjun Cheng, Yushe Yang, Guozhang Jin, Xuechu Zhen
    Schizophrenia Research
    November 2009 (Vol. 115, Issue 1, Pages 41-49)
    Abstract | Full Text | Full-Text PDF (393 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 925 results   Next 20>

Results Page:  [1]  2  3  4  5  6  7  >

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.